1. In-Hospital Treatment for Heart Failure: New Approaches and a Renewed Sense of Hope?

3. Heart Failure: In the United States

4. 5-Year Outcomes for Heart Failure

5. Heart Failure in Europe

6. What Are the Goals for Uptitration?

7. Use of Medications in Patients Hospitalized With HF

8. How Do You Know When the Patient Is Decongested and Ready for Discharge?

9. Predischarge BNP Assay for Identifying Patients at High Risk for Readmission After Decompensated Heart Failure

10. Beta Blockade Use in Acute HF

11. Beta Blockade Use in Acute HF (cont)

12. Starting Beta Blockade in a De Novo HF Patient

13. Use of MRAs in Heart Failure Management

14. Impact of Evidence-Based HF Therapy Use at Hospital Discharge on Treatment Rates During Follow-Up

15. Recent Trials With Sacubitril/Valsartan

16. PIONEER HF: NT-proBNP Changes at 7 Days With Sacubitril/Valsartan

17. Transitioning From ACE Inhibitor or ARB to ARNI or Starting ARNI in the ACE Inhibitor/ARB De Novo Patient: Key Points From PIONEER HF

18. PIONEER HF: Key Subgroup Analyses

19. Benefit of Adding Ivabradine to an Inotrope in Severe Systolic Dysfunction

20. Ivabradine for Heart Failure

21. Early Discharge Period: Goals for Care

22. Early Discharge Period: Goals for Care (cont)

23. Abbreviations